INN or brand name drug prescriptions: a multilevel, cross-sectional study in general practice View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-10-27

AUTHORS

Florent De Bruyne, Arnaud Ponçon, Joris Giai, Xavier Dode, David Darmon, Cyrille Colin, François Gueyffier, Laurent Letrilliart

ABSTRACT

PurposeThe prescription in International Nonproprietary Names (INN) is a legal obligation for all physicians in France since January 2015. The objective of this study was to analyze the frequency and main factors of INN drug prescribing in general practice.MethodsMulticenter cross-sectional study conducted with 11 interns acting as observers of 23 GP trainers between November 2015 and January 2016. Two evaluators analyzed all GPs’ drug prescriptions to identify INN or brand name prescriptions.ResultsThe database included 4957 drugs prescribed during 1647 visits. Of these, 1462 (29.5% [95% CI 28.2–30.8%]) were prescribed only in INN. According to the multivariate analyses, the factors favoring INN prescribing were as follows: at the drug level, its initial prescribing (OR = 1.4), a nonspecific prescribing objective (OR = 1.6), its listing in the generic drug index with (OR = 7.7) or without (OR = 2.9) efficiency objective included in the payment for public health objectives (PPHO) program, and the oral route of administration (OR from 0.4 for the percutaneous route to 0.2 for the pulmonary route); at the patient level, the male gender (OR = 1.3), the age of 15 years or more (OR = 1.9), and the absence of a long-term condition (OR = 1.3); at the physician level, the reception of a public healthcare insurance representative (OR = 4.1), the nonreception of pharmaceutical sales representatives (OR = 3.0), and the urban practice environment (OR = 2.8).ConclusionsIn 2015, less than one third of drugs were prescribed in INN only in general practice. The use of various incentives and regulatory measures is likely to favor the prescription of INNs by practitioners. More... »

PAGES

275-283

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00228-018-2580-8

DOI

http://dx.doi.org/10.1007/s00228-018-2580-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1107880457

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30368571


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cross-Sectional Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Prescriptions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drugs, Generic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "France", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "General Practice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Health Expenditures", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multivariate Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Practice Patterns, Physicians'", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prescription Drugs", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Coll\u00e8ge universitaire de m\u00e9decine g\u00e9n\u00e9rale, Univ. Lyon, Universit\u00e9 Claude Bernard Lyon 1, Universit\u00e9 Saint-Etienne, F-42023, Saint-Etienne, France", 
          "id": "http://www.grid.ac/institutes/grid.6279.a", 
          "name": [
            "Coll\u00e8ge universitaire de m\u00e9decine g\u00e9n\u00e9rale, Univ. Lyon, Universit\u00e9 Claude Bernard Lyon 1, Universit\u00e9 Saint-Etienne, F-42023, Saint-Etienne, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Bruyne", 
        "givenName": "Florent", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Coll\u00e8ge universitaire de m\u00e9decine g\u00e9n\u00e9rale, Univ. Lyon, Universit\u00e9 Claude Bernard Lyon 1, Universit\u00e9 Saint-Etienne, F-42023, Saint-Etienne, France", 
          "id": "http://www.grid.ac/institutes/grid.6279.a", 
          "name": [
            "Coll\u00e8ge universitaire de m\u00e9decine g\u00e9n\u00e9rale, Univ. Lyon, Universit\u00e9 Claude Bernard Lyon 1, Universit\u00e9 Saint-Etienne, F-42023, Saint-Etienne, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pon\u00e7on", 
        "givenName": "Arnaud", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service de Biostatistique, Hospices Civils de Lyon, F-69003, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.413852.9", 
          "name": [
            "Universit\u00e9 Lyon 1, F-69622, Villeurbanne, France", 
            "Laboratoire de Biom\u00e9trie et Biologie \u00c9volutive, CNRS, UMR5558, F-69622, Villeurbanne, France", 
            "Service de Biostatistique, Hospices Civils de Lyon, F-69003, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giai", 
        "givenName": "Joris", 
        "id": "sg:person.01051016605.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051016605.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "D\u00e9partement de Pharmacie, Hospices Civils de Lyon, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.413852.9", 
          "name": [
            "D\u00e9partement de Pharmacie, Hospices Civils de Lyon, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dode", 
        "givenName": "Xavier", 
        "id": "sg:person.012463425573.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012463425573.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "UMR 912 Sesstim Inserm, Marseille, France", 
          "id": "http://www.grid.ac/institutes/grid.7429.8", 
          "name": [
            "D\u00e9partement d\u2019Enseignement et de Recherche en M\u00e9decine G\u00e9n\u00e9rale, Universit\u00e9 de Nice Sophia-Antipolis, Nice, France", 
            "UMR 912 Sesstim Inserm, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Darmon", 
        "givenName": "David", 
        "id": "sg:person.01002305503.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002305503.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "P\u00f4le IMER des Hospices Civils de Lyon, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.413852.9", 
          "name": [
            "Universit\u00e9 Lyon 1, F-69622, Villeurbanne, France", 
            "Health Services and Performance Research, HESPER EA 7425, Lyon Cedex 3, France", 
            "P\u00f4le IMER des Hospices Civils de Lyon, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Colin", 
        "givenName": "Cyrille", 
        "id": "sg:person.0612253637.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612253637.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "UMR 5558, CNRS & Universit\u00e9 Claude Bernard Lyon 1, 69000, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.7849.2", 
          "name": [
            "Service de Pharmaco-Toxicologie, Hospices Civils de Lyon, 69000, Lyon, France", 
            "UMR 5558, CNRS & Universit\u00e9 Claude Bernard Lyon 1, 69000, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gueyffier", 
        "givenName": "Fran\u00e7ois", 
        "id": "sg:person.0660631343.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660631343.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Health Services and Performance Research, HESPER EA 7425, Lyon Cedex 3, France", 
          "id": "http://www.grid.ac/institutes/grid.503213.6", 
          "name": [
            "Coll\u00e8ge universitaire de m\u00e9decine g\u00e9n\u00e9rale, Univ. Lyon, Universit\u00e9 Claude Bernard Lyon 1, Universit\u00e9 Saint-Etienne, F-42023, Saint-Etienne, France", 
            "Health Services and Performance Research, HESPER EA 7425, Lyon Cedex 3, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Letrilliart", 
        "givenName": "Laurent", 
        "id": "sg:person.01354706717.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354706717.33"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/s12909-016-0649-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014072465", 
          "https://doi.org/10.1186/s12909-016-0649-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/2050-6511-14-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024059082", 
          "https://doi.org/10.1186/2050-6511-14-1"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-10-27", 
    "datePublishedReg": "2018-10-27", 
    "description": "PurposeThe prescription in International Nonproprietary Names (INN) is a legal obligation for all physicians in France since January 2015. The objective of this study was to analyze the frequency and main factors of INN drug prescribing in general practice.MethodsMulticenter cross-sectional study conducted with 11 interns acting as observers of 23 GP trainers between November 2015 and January 2016. Two evaluators analyzed all GPs\u2019 drug prescriptions to identify INN or brand name prescriptions.ResultsThe database included 4957 drugs prescribed during 1647 visits. Of these, 1462 (29.5% [95% CI 28.2\u201330.8%]) were prescribed only in INN. According to the multivariate analyses, the factors favoring INN prescribing were as follows: at the drug level, its initial prescribing (OR\u2009=\u20091.4), a nonspecific prescribing objective (OR\u2009=\u20091.6), its listing in the generic drug index with (OR\u2009=\u20097.7) or without (OR\u2009=\u20092.9) efficiency objective included in the payment for public health objectives (PPHO) program, and the oral route of administration (OR from 0.4 for the percutaneous route to 0.2 for the pulmonary route); at the patient level, the male gender (OR\u2009=\u20091.3), the age of 15\u00a0years or more (OR\u2009=\u20091.9), and the absence of a long-term condition (OR\u2009=\u20091.3); at the physician level, the reception of a public healthcare insurance representative (OR\u2009=\u20094.1), the nonreception of pharmaceutical sales representatives (OR\u2009=\u20093.0), and the urban practice environment (OR\u2009=\u20092.8).ConclusionsIn 2015, less than one third of drugs were prescribed in INN only in general practice. The use of various incentives and regulatory measures is likely to favor the prescription of INNs by practitioners.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00228-018-2580-8", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "75"
      }
    ], 
    "keywords": [
      "cross-sectional study", 
      "general practice", 
      "drug prescriptions", 
      "International Nonproprietary Names", 
      "long-term conditions", 
      "third of drugs", 
      "initial prescribing", 
      "drug prescribing", 
      "male gender", 
      "brand name prescriptions", 
      "patient level", 
      "drug levels", 
      "physician level", 
      "oral route", 
      "multivariate analysis", 
      "pharmaceutical sales representatives", 
      "INN prescribing", 
      "prescribing", 
      "prescription", 
      "practice environment", 
      "insurance representatives", 
      "GP trainers", 
      "drugs", 
      "nonproprietary name", 
      "Drug Index", 
      "levels", 
      "physicians", 
      "administration", 
      "study", 
      "visits", 
      "age", 
      "factors", 
      "GPs", 
      "objective", 
      "practice", 
      "third", 
      "gender", 
      "years", 
      "index", 
      "interns", 
      "absence", 
      "practitioners", 
      "database", 
      "measures", 
      "trainers", 
      "use", 
      "frequency", 
      "program", 
      "sales representatives", 
      "evaluators", 
      "main factors", 
      "analysis", 
      "route", 
      "observers", 
      "listing", 
      "conditions", 
      "representatives", 
      "France", 
      "legal obligations", 
      "name", 
      "multilevel", 
      "regulatory measures", 
      "payments", 
      "objective programs", 
      "environment", 
      "obligations", 
      "incentives", 
      "reception", 
      "efficiency objectives", 
      "PurposeThe prescription", 
      "INN drug prescribing", 
      "MethodsMulticenter cross-sectional study", 
      "name prescriptions", 
      "nonspecific prescribing objective", 
      "prescribing objective", 
      "generic drug index", 
      "public health objectives (PPHO) program", 
      "health objectives (PPHO) program", 
      "public healthcare insurance representative", 
      "healthcare insurance representative", 
      "nonreception", 
      "urban practice environment", 
      "ConclusionsIn 2015", 
      "prescription of INNs", 
      "brand name drug prescriptions", 
      "name drug prescriptions"
    ], 
    "name": "INN or brand name drug prescriptions: a multilevel, cross-sectional study in general practice", 
    "pagination": "275-283", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1107880457"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00228-018-2580-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30368571"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00228-018-2580-8", 
      "https://app.dimensions.ai/details/publication/pub.1107880457"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:42", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_793.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00228-018-2580-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00228-018-2580-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00228-018-2580-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00228-018-2580-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00228-018-2580-8'


 

This table displays all metadata directly associated to this object as RDF triples.

277 TRIPLES      22 PREDICATES      127 URIs      117 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00228-018-2580-8 schema:about N0738cdc8e7cc41a3b9839c3ae4068106
2 N13988048549d4c03974abde02f06fa61
3 N31e5121170ee430ebf9cc6957590b012
4 N4b62e4c0ef884868ab18723d8a316de0
5 N5a8f194a928644bb8780f5269698ddbc
6 N68de3a064fa6465c869b2edcc25229c1
7 N770ac485c22c47628ad92734043b33db
8 Na1398ab73060430fbc44b3b226904169
9 Naf369a5fb4484948ad4fc40f779d32b4
10 Nb3c7e152fc114ea9b4e493bb00a7fd34
11 Nc7b34f94c4964ba8a492aee8eb32e7db
12 Ndefc1a78435d471e96beebc81502dc54
13 Ne7f79569b0df48c9aab66077c6eaebb4
14 anzsrc-for:11
15 anzsrc-for:1117
16 schema:author N540dfa01cf0a4712a5de99915ff1f578
17 schema:citation sg:pub.10.1186/2050-6511-14-1
18 sg:pub.10.1186/s12909-016-0649-6
19 schema:datePublished 2018-10-27
20 schema:datePublishedReg 2018-10-27
21 schema:description PurposeThe prescription in International Nonproprietary Names (INN) is a legal obligation for all physicians in France since January 2015. The objective of this study was to analyze the frequency and main factors of INN drug prescribing in general practice.MethodsMulticenter cross-sectional study conducted with 11 interns acting as observers of 23 GP trainers between November 2015 and January 2016. Two evaluators analyzed all GPs’ drug prescriptions to identify INN or brand name prescriptions.ResultsThe database included 4957 drugs prescribed during 1647 visits. Of these, 1462 (29.5% [95% CI 28.2–30.8%]) were prescribed only in INN. According to the multivariate analyses, the factors favoring INN prescribing were as follows: at the drug level, its initial prescribing (OR = 1.4), a nonspecific prescribing objective (OR = 1.6), its listing in the generic drug index with (OR = 7.7) or without (OR = 2.9) efficiency objective included in the payment for public health objectives (PPHO) program, and the oral route of administration (OR from 0.4 for the percutaneous route to 0.2 for the pulmonary route); at the patient level, the male gender (OR = 1.3), the age of 15 years or more (OR = 1.9), and the absence of a long-term condition (OR = 1.3); at the physician level, the reception of a public healthcare insurance representative (OR = 4.1), the nonreception of pharmaceutical sales representatives (OR = 3.0), and the urban practice environment (OR = 2.8).ConclusionsIn 2015, less than one third of drugs were prescribed in INN only in general practice. The use of various incentives and regulatory measures is likely to favor the prescription of INNs by practitioners.
22 schema:genre article
23 schema:inLanguage en
24 schema:isAccessibleForFree false
25 schema:isPartOf N0eb322ab38594ed69780db1af6ff4990
26 N3b2de2ef64fa4dbcb6bc076a8fbf0b74
27 sg:journal.1054337
28 schema:keywords ConclusionsIn 2015
29 Drug Index
30 France
31 GP trainers
32 GPs
33 INN drug prescribing
34 INN prescribing
35 International Nonproprietary Names
36 MethodsMulticenter cross-sectional study
37 PurposeThe prescription
38 absence
39 administration
40 age
41 analysis
42 brand name drug prescriptions
43 brand name prescriptions
44 conditions
45 cross-sectional study
46 database
47 drug levels
48 drug prescribing
49 drug prescriptions
50 drugs
51 efficiency objectives
52 environment
53 evaluators
54 factors
55 frequency
56 gender
57 general practice
58 generic drug index
59 health objectives (PPHO) program
60 healthcare insurance representative
61 incentives
62 index
63 initial prescribing
64 insurance representatives
65 interns
66 legal obligations
67 levels
68 listing
69 long-term conditions
70 main factors
71 male gender
72 measures
73 multilevel
74 multivariate analysis
75 name
76 name drug prescriptions
77 name prescriptions
78 nonproprietary name
79 nonreception
80 nonspecific prescribing objective
81 objective
82 objective programs
83 obligations
84 observers
85 oral route
86 patient level
87 payments
88 pharmaceutical sales representatives
89 physician level
90 physicians
91 practice
92 practice environment
93 practitioners
94 prescribing
95 prescribing objective
96 prescription
97 prescription of INNs
98 program
99 public health objectives (PPHO) program
100 public healthcare insurance representative
101 reception
102 regulatory measures
103 representatives
104 route
105 sales representatives
106 study
107 third
108 third of drugs
109 trainers
110 urban practice environment
111 use
112 visits
113 years
114 schema:name INN or brand name drug prescriptions: a multilevel, cross-sectional study in general practice
115 schema:pagination 275-283
116 schema:productId N509964db786b4ecfa8f8805c7b62e9d5
117 N50a28acc3f1a45d9b611f1c9593c7b8f
118 Nf0e8b149eaae48c694f042d01856dc2a
119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107880457
120 https://doi.org/10.1007/s00228-018-2580-8
121 schema:sdDatePublished 2021-12-01T19:42
122 schema:sdLicense https://scigraph.springernature.com/explorer/license/
123 schema:sdPublisher N6d93c9de144342c78fba606e7dceafa7
124 schema:url https://doi.org/10.1007/s00228-018-2580-8
125 sgo:license sg:explorer/license/
126 sgo:sdDataset articles
127 rdf:type schema:ScholarlyArticle
128 N0738cdc8e7cc41a3b9839c3ae4068106 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Male
130 rdf:type schema:DefinedTerm
131 N0ab851e9c9654d18b0296963adbf2e27 rdf:first sg:person.01002305503.76
132 rdf:rest N958b5bd6bc4f4a969a4a5da5933ababa
133 N0eb322ab38594ed69780db1af6ff4990 schema:volumeNumber 75
134 rdf:type schema:PublicationVolume
135 N13988048549d4c03974abde02f06fa61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Drug Prescriptions
137 rdf:type schema:DefinedTerm
138 N25fc759c45cd49b48b202b2d64ac3c96 rdf:first sg:person.01354706717.33
139 rdf:rest rdf:nil
140 N31e5121170ee430ebf9cc6957590b012 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Multivariate Analysis
142 rdf:type schema:DefinedTerm
143 N3b2de2ef64fa4dbcb6bc076a8fbf0b74 schema:issueNumber 2
144 rdf:type schema:PublicationIssue
145 N4b62e4c0ef884868ab18723d8a316de0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Prescription Drugs
147 rdf:type schema:DefinedTerm
148 N509964db786b4ecfa8f8805c7b62e9d5 schema:name pubmed_id
149 schema:value 30368571
150 rdf:type schema:PropertyValue
151 N50a28acc3f1a45d9b611f1c9593c7b8f schema:name dimensions_id
152 schema:value pub.1107880457
153 rdf:type schema:PropertyValue
154 N540dfa01cf0a4712a5de99915ff1f578 rdf:first Nd11ad1a6cd154b47a01eaa88e15ebe72
155 rdf:rest Nae5ab7c89e6744759a7ac804543cae14
156 N5a8f194a928644bb8780f5269698ddbc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Health Expenditures
158 rdf:type schema:DefinedTerm
159 N68de3a064fa6465c869b2edcc25229c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name France
161 rdf:type schema:DefinedTerm
162 N6d93c9de144342c78fba606e7dceafa7 schema:name Springer Nature - SN SciGraph project
163 rdf:type schema:Organization
164 N770ac485c22c47628ad92734043b33db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Cross-Sectional Studies
166 rdf:type schema:DefinedTerm
167 N8d59a4c8fcfb464b8dfc182a4312092a rdf:first sg:person.012463425573.88
168 rdf:rest N0ab851e9c9654d18b0296963adbf2e27
169 N958b5bd6bc4f4a969a4a5da5933ababa rdf:first sg:person.0612253637.66
170 rdf:rest Nb1940fc0ec904c2b883d2c489e9c0c6a
171 Na1398ab73060430fbc44b3b226904169 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name General Practice
173 rdf:type schema:DefinedTerm
174 Nae5ab7c89e6744759a7ac804543cae14 rdf:first Nb9817f246dd94c9ea5ec055d7d411ece
175 rdf:rest Nda8029f9688740ccb5200506977b0208
176 Naf369a5fb4484948ad4fc40f779d32b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Practice Patterns, Physicians'
178 rdf:type schema:DefinedTerm
179 Nb1940fc0ec904c2b883d2c489e9c0c6a rdf:first sg:person.0660631343.90
180 rdf:rest N25fc759c45cd49b48b202b2d64ac3c96
181 Nb3c7e152fc114ea9b4e493bb00a7fd34 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Adolescent
183 rdf:type schema:DefinedTerm
184 Nb9817f246dd94c9ea5ec055d7d411ece schema:affiliation grid-institutes:grid.6279.a
185 schema:familyName Ponçon
186 schema:givenName Arnaud
187 rdf:type schema:Person
188 Nc7b34f94c4964ba8a492aee8eb32e7db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Humans
190 rdf:type schema:DefinedTerm
191 Nd11ad1a6cd154b47a01eaa88e15ebe72 schema:affiliation grid-institutes:grid.6279.a
192 schema:familyName De Bruyne
193 schema:givenName Florent
194 rdf:type schema:Person
195 Nda8029f9688740ccb5200506977b0208 rdf:first sg:person.01051016605.45
196 rdf:rest N8d59a4c8fcfb464b8dfc182a4312092a
197 Ndefc1a78435d471e96beebc81502dc54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Drugs, Generic
199 rdf:type schema:DefinedTerm
200 Ne7f79569b0df48c9aab66077c6eaebb4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Female
202 rdf:type schema:DefinedTerm
203 Nf0e8b149eaae48c694f042d01856dc2a schema:name doi
204 schema:value 10.1007/s00228-018-2580-8
205 rdf:type schema:PropertyValue
206 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
207 schema:name Medical and Health Sciences
208 rdf:type schema:DefinedTerm
209 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
210 schema:name Public Health and Health Services
211 rdf:type schema:DefinedTerm
212 sg:journal.1054337 schema:issn 0031-6970
213 1432-1041
214 schema:name European Journal of Clinical Pharmacology
215 schema:publisher Springer Nature
216 rdf:type schema:Periodical
217 sg:person.01002305503.76 schema:affiliation grid-institutes:grid.7429.8
218 schema:familyName Darmon
219 schema:givenName David
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002305503.76
221 rdf:type schema:Person
222 sg:person.01051016605.45 schema:affiliation grid-institutes:grid.413852.9
223 schema:familyName Giai
224 schema:givenName Joris
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051016605.45
226 rdf:type schema:Person
227 sg:person.012463425573.88 schema:affiliation grid-institutes:grid.413852.9
228 schema:familyName Dode
229 schema:givenName Xavier
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012463425573.88
231 rdf:type schema:Person
232 sg:person.01354706717.33 schema:affiliation grid-institutes:grid.503213.6
233 schema:familyName Letrilliart
234 schema:givenName Laurent
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354706717.33
236 rdf:type schema:Person
237 sg:person.0612253637.66 schema:affiliation grid-institutes:grid.413852.9
238 schema:familyName Colin
239 schema:givenName Cyrille
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612253637.66
241 rdf:type schema:Person
242 sg:person.0660631343.90 schema:affiliation grid-institutes:grid.7849.2
243 schema:familyName Gueyffier
244 schema:givenName François
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660631343.90
246 rdf:type schema:Person
247 sg:pub.10.1186/2050-6511-14-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024059082
248 https://doi.org/10.1186/2050-6511-14-1
249 rdf:type schema:CreativeWork
250 sg:pub.10.1186/s12909-016-0649-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014072465
251 https://doi.org/10.1186/s12909-016-0649-6
252 rdf:type schema:CreativeWork
253 grid-institutes:grid.413852.9 schema:alternateName Département de Pharmacie, Hospices Civils de Lyon, Lyon, France
254 Pôle IMER des Hospices Civils de Lyon, Lyon, France
255 Service de Biostatistique, Hospices Civils de Lyon, F-69003, Lyon, France
256 schema:name Département de Pharmacie, Hospices Civils de Lyon, Lyon, France
257 Health Services and Performance Research, HESPER EA 7425, Lyon Cedex 3, France
258 Laboratoire de Biométrie et Biologie Évolutive, CNRS, UMR5558, F-69622, Villeurbanne, France
259 Pôle IMER des Hospices Civils de Lyon, Lyon, France
260 Service de Biostatistique, Hospices Civils de Lyon, F-69003, Lyon, France
261 Université Lyon 1, F-69622, Villeurbanne, France
262 rdf:type schema:Organization
263 grid-institutes:grid.503213.6 schema:alternateName Health Services and Performance Research, HESPER EA 7425, Lyon Cedex 3, France
264 schema:name Collège universitaire de médecine générale, Univ. Lyon, Université Claude Bernard Lyon 1, Université Saint-Etienne, F-42023, Saint-Etienne, France
265 Health Services and Performance Research, HESPER EA 7425, Lyon Cedex 3, France
266 rdf:type schema:Organization
267 grid-institutes:grid.6279.a schema:alternateName Collège universitaire de médecine générale, Univ. Lyon, Université Claude Bernard Lyon 1, Université Saint-Etienne, F-42023, Saint-Etienne, France
268 schema:name Collège universitaire de médecine générale, Univ. Lyon, Université Claude Bernard Lyon 1, Université Saint-Etienne, F-42023, Saint-Etienne, France
269 rdf:type schema:Organization
270 grid-institutes:grid.7429.8 schema:alternateName UMR 912 Sesstim Inserm, Marseille, France
271 schema:name Département d’Enseignement et de Recherche en Médecine Générale, Université de Nice Sophia-Antipolis, Nice, France
272 UMR 912 Sesstim Inserm, Marseille, France
273 rdf:type schema:Organization
274 grid-institutes:grid.7849.2 schema:alternateName UMR 5558, CNRS & Université Claude Bernard Lyon 1, 69000, Lyon, France
275 schema:name Service de Pharmaco-Toxicologie, Hospices Civils de Lyon, 69000, Lyon, France
276 UMR 5558, CNRS & Université Claude Bernard Lyon 1, 69000, Lyon, France
277 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...